NCT04059887View on ClinicalTrials.gov

Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY]

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 18, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

June 30, 2022

Conditions
Lung Neoplasm Malignant
Interventions
DRUG

Atezolizumab Injection [Tecentriq]

Blood sampling will be performed before and after 3rd cycle of atezolizumab for evaluation of tumor mutation burden

Trial Locations (1)

58128

Chonnam National University Hwasun Hospital, Hwasun

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

Chonnam National University Hospital

OTHER

NCT04059887 - Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY] | Biotech Hunter | Biotech Hunter